RESEARCH TRIANGLE PARK, NC, Nov. 5, 2020 — Pappas Capital, a leading venture capital firm focused on advancing life sciences, today announced that its portfolio company, VelosBio Inc. (“VelosBio” or the...
Bayhill focused on the translation of research into therapeutics for the treatment of autoimmune diseases. The company pursued DNA-antigen vaccines and oligonucleotides that were specifically designed to promote immune intolerance. The company was dissolved in 2012.
Bayhill Therapeutics
San Mateo, CA
© 2020 Pappas Capital, LLC. ALL RIGHTS RESERVED.